Pfizer CentreSource promotes Cristin Grove

To director of Global Contract Manufacturing

Pfizer CentreSource, (PCS), an operating unit within Pfizer Global Supply (PGS), has promoted Cristin B. Grove to director, Global Contract Manufacturing for PCS. With Pfizer since 1993, Grove most recently served as business development manager for PGS.

‘Cristin brings an unbeatable combination of industry expertise, a keenly advanced skill set, and enthusiasm to her new role. She will be a competitive advantage to Pfizer CentreSource and to Pfizer moving forward,’ said PCS president Michael Kosko.

Positions held by Grove earlier in her career include: senior manager/team leader, Non-sterile Liquids Operations (Pfizer Kalamazoo, Michigan); manager/team leader, Manufacturing (Pfizer Holland, Michigan); and assistant production manager (Pfizer Little Island, Cork, Ireland).

Prior to joining Pfizer, Grove worked for Parke-Davis, a predecessor of CentreSource, as an environmental engineer.

You may also like

Manufacturing

Samsung Biologics and Pfizer's collaboration for manufacturing of biosimilars

Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
Manufacturing

Tickets now on sale for 2023 Manufacturing Chemist Live

Super early bird tickets are now on sale for the annual conference due to take place in Birmingham on 24 – 25 May 2023
Manufacturing

Manufacturing Chemist LIVE 2023: Become an official sponsor

Taking place on 24 – 25 May 2023 at the National Conference Centre in Birmingham, the annual Manufacturing Chemist LIVE event is offering a unique opportunity to get your name recognised across the pharmaceutical sector as well as those using cleanrooms
Manufacturing

AGC to support Pfizer-BioNTech Omicron vaccine

Plasmid DNA from AGC is already supplied as a starting material for the companies' COVID-19 vaccine
Manufacturing

Eurofarma to manufacture Pfizer-BioNTech doses for Latin America

Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be distributed within Latin America
Manufacturing

Biovac to manufacture Pfizer-BioNTech vaccine for African Union

Pfizer and BioNTech expect the Cape Town facility to be incorporated into the vaccine supply chain by the end of 2021
Manufacturing

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
Subscribe now